Do you want to read an article? Please log in or register.
Effect of fully automated closed-loop insulin delivery using faster aspart versus standard aspart on gluco-regulatory hormones in type 2 diabetes
Type 2 DiabetesGlycemic Control
Related content
Diabetes - GeneralType 2 DiabetesGlycemic Control
Faster Aspart Versus Insulin Aspart As Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
Diabetes Care.
Bowering K, Case C, Harvey J, Reeves M, Sampson M, Strzinek R, Bretler DM, Bang RB, Bode BW
doi: 10.2337/dc16-1770.
COMMENTED
Type 2 DiabetesGlycemic Control
Effect of nutrition on postprandial glucose control in hospitalized patients with type 2 diabetes receiving fully automated closed-loop insulin therapy
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Banholzer N, Herzig D, Piazza C, Alvarez Martinez M, Nakas CT, Kosinski C, Feuerriegel S, Hovorka R, Bally L
doi: 10.1111/dom.14187
COMMENTED
Diabetes - GeneralType 1 Diabetes
Hybrid closed-loop glucose control with faster insulin aspart (Fiasp) compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomised, crossover study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Boughton CK, Hartnell S, Thabit H, Poettler T, Herzig D, Wilinska ME, Ashcroft NL, Sibayan J, Cohen N, Calhoun P, Bally L, Mader JK, Evans M, Leelarathna L, Hovorka R
doi: 10.1111/dom.14355
COMMENTED
Type 2 Diabetes
Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
Diabet Med.
Bowering K, Harvey J, Kolaczynski JW, Snyder JW, Bode BW
doi: 10.1111/dme.13866.
Diabetes - GeneralType 1 Diabetes
Hypoglycaemia Incidence and Recovery During Home Use of Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
Diabetes Obes Metab.
Ruan Y, Bally L, Thabit H, Leelarathna L, Hartnell S, Tauschmann M, Wilinska ME, Evans ML, Mader JK, Kojzar H, Dellweg S, Benesch C, Arnolds S, Pieber TR, Hovorka R
doi: 10.1111/dom.13304.
COMMENTED
Type 1 Diabetes
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Lancet.
Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam Consortium
doi: 10.1016/S0140-6736(18)31947-0.
Diabetes - GeneralType 2 Diabetes
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial.
Lancet Diabetes Endocrinol.
Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, Evans ML, Coll AP, Hovorka R
doi: 10.1016/S2213-
Diabetes - GeneralType 1 Diabetes
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Lancet Diabetes Endocrinol.
Bally L, Thabit H, Kojzar H, Mader JK, Qerimi-Hyseni J, Hartnell S, Tauschmann M, Allen JM, Wilinska ME, Pieber TR, Evans ML, Hovorka R
doi: 10.1016/
Diabetes - GeneralType 1 DiabetesGlycemic Control
Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
Diabetes Care.
Stewart ZA, Wilinska ME, Hartnell S, O'Neil LK, Rayman G, Scott EM, Barnard K, Farrington C, Hovorka R, Murphy HR
doi: 10.2337/dc17-2534.